I think this presentation gives you an idea how IF is performing compared to vitamins...Same market different structure and result.
I would like to see Citi & Goldman Sachs analysts come out and upgrade their earnings forecasts on A2M & BAL after today. They clearly got it wrong on a China slowdown for IF demand.
BAL Price at posting:
$11.19 Sentiment: Buy Disclosure: Held